Tech Company Financing Transactions

Avidia Funding Round

Avidia, operating out of Mountain View, received $28.5 million from Morgenthaler Ventures, Alloy Ventures and Amgen Ventures.

Transaction Overview

Company Name
Avidia
Announced On
5/5/2005
Transaction Type
Venture Equity
Amount
$28,500,000
Round
Series B
Investors

Morgenthaler Ventures (Lead Investor) (Ralph Christoffersen)

Alloy Ventures

Amgen Ventures

MedImmune Ventures (Franklin Top)

TPG Capital

Proceeds Purpose
This funding allows us to advance our lead product into clinical testing, broaden our product pipeline, and expand the therapeutic applicability of our technology.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2450 Bayshore Pkwy. 200
Mountain View, CA 94043
USA
Phone
(650) 404-2000
Website
www.avidia.com
Email Address
Not Recorded
Overview
Avidia, a biopharmaceuticals company founded in 2003, is committed to developing medicines for patients with serious unmet medical conditions.
Profile
Avidia LinkedIn Company Profile
Social Media
Avidia Company Twitter Account
Company News
Avidia News
Facebook
Avidia on Facebook
YouTube
Avidia on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/4/2005: Worksoft venture capital transaction
Next: 5/5/2005: Velox Semiconductor venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.